Healthpeak Properties Inc

DOCNYSE

Trade with Public

$20.38

-0.03-0.15%

最終更新: Nov 12, 8:21 AM

概要ニュースチャート業績予想目標株価財務センチメント株主構成配当比較株式レポート

配当金: 配当落ち日は明日です。

Healthpeak Properties (DOC) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Healthpeak Properties (DOC) stock.

Analyst Consensus — 19 Analysts

12Buy

7Hold

# Analysts19

Latest Upgrades and Downgrades for Healthpeak Properties Stock

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	UBS	—	PT Raise	Neutral	$20→$22
—	Evercore ISI Group	James Kammert	PT Raise	In-Line	$22→$23
—	Cantor Fitzgerald	Richard Anderson	PT Cut	Neutral	$23→$21
—	Wells Fargo	James Feldman	PT Cut	Equal-Weight	$22→$19
—	UBS	—	PT Cut	Neutral	$22→$20
—	Barclays	Richard Hightower	PT Cut	Equal-Weight	$24→$21
—	Evercore ISI Group	James Kammert	PT Cut	In-Line	$23→$22
—	Jefferies	Joe Dickstein	Assumes	Hold	$22→$21
—	Barclays	Richard Hightower	PT Raise	Equal-Weight	$23→$24
—	Baird	Amanda Sweitzer	PT Raise	Outperform	$21→$24
—	Citigroup	Nick Joseph	PT Raise	Neutral	$20→$22
—	RBC Capital	Michael Carroll	PT Raise	Outperform	$21→$24
—	Cantor Fitzgerald	Richard Anderson	PT Raise	Neutral	$20→$23
—	Wells Fargo	John Kilichowski	PT Raise	Equal-Weight	$20→$22
—	UBS	—	PT Raise	Neutral	$19→$22
—	Barclays	Richard Hightower	Initiate	Overweight→Equal-Weight	$23
—	Mizuho	Vikram Malhotra	PT Raise	Outperform	$21→$24
—	JP Morgan	Michael Mueller	PT Raise	Neutral	$18→$21
—	Raymond James	David Rodgers	Reinstates	Outperform→Market Perform	—
—	BMO Capital	Juan Sanabria	PT Raise	Outperform	$20→$24

Healthpeak Properties Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Healthpeak Properties (DOC) Stock Price Target 2026

Latest Upgrades and Downgrades for Healthpeak Properties Stock

Healthpeak Properties (DOC) Stock Price Target 2026

Latest Upgrades and Downgrades for Healthpeak Properties Stock

Analyst Ratings News

PRO
UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

PRO
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23

PRO
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21

PRO
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19

PRO
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21

People Also Watch

People Also Watch

Analyst Ratings News

PRO
UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

PRO
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23

PRO
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21

PRO
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19

PRO
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21

Healthpeak Properties Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Healthpeak Properties (DOC) Stock Price Target 2026

Latest Upgrades and Downgrades for Healthpeak Properties Stock

Healthpeak Properties (DOC) Stock Price Target 2026

Latest Upgrades and Downgrades for Healthpeak Properties Stock

Analyst Ratings News

PROUBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

PROEvercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23

PROCantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21

PROWells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19

PROUBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20

PROBarclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21

People Also Watch

People Also Watch

Analyst Ratings News

PROUBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

PROEvercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23

PROCantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21

PROWells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19

PROUBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20

PROBarclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21

PRO
UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

PRO
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23

PRO
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21

PRO
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19

PRO
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21

PRO
UBS Maintains Neutral on Healthpeak Properties, Raises Price Target to $22

PRO
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Raises Price Target to $23

PRO
Cantor Fitzgerald Maintains Neutral on Healthpeak Properties, Lowers Price Target to $21

PRO
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19

PRO
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20

PRO
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21